TonyShare(839167)
Search documents
同享科技2026年关注点:关联交易收购、业绩预告下滑及银行授信
Jing Ji Guan Cha Wang· 2026-02-12 06:57
Group 1 - The company plans to acquire the land use rights and buildings of Suzhou Gaohua Precision Machinery Co., Ltd. to accelerate capacity construction and shorten the expansion cycle, which is an associated transaction that requires attention to the subsequent delivery and integration progress [2] - The company announced a profit forecast on January 29, 2026, expecting a net profit decline of 47.98% to 59.80% for 2025, translating to approximately 17 million to 22 million yuan [3] - As of the end of 2025, the wholly-owned subsidiaries both domestically and internationally have not officially commenced production, with related depreciation costs currently dragging down profits; future production operations may become a turning point for performance [4] Group 2 - The company obtained a bank credit line of 2.3 billion yuan on February 9, 2026, primarily to supplement working capital; it is necessary to observe whether the actual allocation of funds supports business expansion and technological upgrades [5] - The second exercise period of the equity incentive plan was completed on the same day, with 100% exercise by nine core members, which may further stabilize the team and boost market confidence [6]
A股光伏设备板块走高:永臻股份触及涨停,聚和材料创新高
Ge Long Hui· 2026-02-11 01:45
Group 1 - The A-share photovoltaic equipment sector experienced an initial surge, with Yongzhen Co. hitting the daily limit up [1] - Juhe Materials reached a new high during the trading session, indicating strong market interest [1] - Other companies such as Laplace, Jinko Energy, Airo Energy, GCL-Poly, and Tongxiang Technology also saw increases in their stock prices [1]
北交所上市公司同享科技登龙虎榜:当日换手率达到22.27%

Sou Hu Cai Jing· 2026-02-10 09:55
(记者 曾健辉) 免责声明:本文内容与数据仅供参考,不构成投资建议,使用前核实。据此操作,风险自担。 每日经济新闻 每经讯,2026年2月10日,北交所上市公司同享科技(920167,收盘价:22.54元)登上龙虎榜,交易方式是连续竞价,披露原因 是当日换手率达到22.27%,成交数量1455.52万股,成交金额3.27亿元。买一席位为国信证券股份有限公司深圳互联网分公司, 买入2722.9万元;卖一席位为东吴证券股份有限公司苏州西北街证券营业部,卖出1262.08万元。 | | 2026-02-10同享科技 (920167) 龙虎榜 | | | | --- | --- | --- | --- | | 序号 | 交易营业部名称 | 买入金额(元) | 卖出金额(元) | | नेट ग | 国信证券股份有限公司深圳互联网分公司 | 27229022.76 | 9475134 34 | | 址2 | 国信证券股份有限公司深圳红岭中路证券营业部 | 15109503.18 | 41782.54 | | ऋ३ | 中信建投证券股份有限公司北京东城分公司 | 8048898.53 | eeee | | ग्रेस | ...
北交所上市公司同享科技登龙虎榜:当日收盘价涨幅达到24.01%
Sou Hu Cai Jing· 2026-02-09 09:08
Core Viewpoint - Tongxiang Technology (920167) experienced a significant price increase of 24.01% on February 9, 2026, leading to its appearance on the stock market's "Dragon and Tiger List" due to high trading volume and value [1][2]. Trading Activity - The total trading volume for Tongxiang Technology on that day was 18.993 million shares, with a total transaction value of 455 million yuan [1]. - The top buying position was held by Dongwu Securities Co., Ltd. Suzhou Northwest Street Securities Business Department, which purchased shares worth approximately 14.204 million yuan [2]. - The top selling position was held by Guosen Securities Co., Ltd. Shenzhen Internet Branch, which sold shares worth approximately 10.513 million yuan [2].
超4600只个股上涨
第一财经· 2026-02-09 07:23
2026.02. 09 本文字数:656,阅读时长大约1分钟 作者 | 一财阿驴 2月9日,A股三大指数集体上涨。截至收盘,沪指涨1.41%,深成指涨2.17%,创业板指涨 2.98%,科创综指涨2.47%。 | 代码 | 名称 | 现价 | 涨跌 | 涨跌幅 | | --- | --- | --- | --- | --- | | 000001 | 上证指数 | 4123.09 c | 57.51 | 1.41% | | 399001 | 深证成指 | 14208.44 c | 301.70 | 2.17% | | 881001 | 万得全A | 6808.50 c | 126.03 | 1.89% | | 000680 | 科创综指 | 1796.86 c | 43.26 | 2.47% | | 399006 | 创业板指 | 3332.77 c | 96.31 | 2.98% | 盘面上,光伏设备、文化传媒、短剧游戏、BC电池板块涨幅居前,油气、燃气板块走低。 具体来看,光伏设备板块表现强势,聚和材料、协鑫集成、TCL中环等多股涨停,同享科技涨超 24%。 | 代码 | 名称 | 米帽子 | 现价 | 主 ...
光伏板块走强,协鑫集成等多股盘中涨停
Bei Jing Shang Bao· 2026-02-09 02:31
Core Viewpoint - The A-share photovoltaic equipment sector has shown significant strength, with multiple stocks reaching their daily limit up on February 9, indicating a bullish trend in the market [1] Company Performance - Xiexin Integrated (协鑫集成) reached a limit up, closing at 5.04 yuan per share, marking its fourth consecutive limit up [1] - TCL Zhonghuan (TCL中环), along with other companies such as Aisxu Co., Ltd. (爱旭股份), also hit the limit up, reflecting strong investor interest [1] - Other companies like Juhua Materials (聚和材料), Yamaton (亚玛顿), and Saiwu Technology (赛伍技术) also experienced limit up, showcasing a broad rally in the sector [1] Market Trends - The overall performance of the photovoltaic equipment sector is characterized by multiple stocks hitting their daily limit up, indicating a robust market sentiment and potential growth in the industry [1] - The surge in stock prices suggests increasing investor confidence and interest in the photovoltaic equipment sector, which may be driven by favorable market conditions or developments in renewable energy [1]
同享科技:2025年第三次临时股东会决议公告
Zheng Quan Ri Bao· 2025-12-29 12:35
证券日报网讯 12月29日,同享科技发布公告称,公司2025年第三次临时股东会审议通过《关于公司及 全资公司2026年度拟向银行申请综合授信额度的议案》。 (文章来源:证券日报) ...
同享科技:关于调整2023年股权激励计划行权价格的公告
Zheng Quan Ri Bao· 2025-12-10 07:12
(文章来源:证券日报) 证券日报网讯 12月9日晚间,同享科技发布公告称,公司于2025年12月9日召开第四届董事会第三次会 议,审议通过了《关于调整2023年股权激励计划行权价格的议案》,将2023年股权激励计划首次授予行 权价格由6.992元/份调整为6.953元/份。 ...
同享科技:关于注销2023年股权激励计划部分股票期权的公告
Zheng Quan Ri Bao· 2025-12-09 14:23
Core Viewpoint - The company announced the cancellation of certain stock options from its 2023 equity incentive plan due to the departure of four incentive targets who no longer meet the eligibility criteria [2] Group 1 - The fourth meeting of the fourth board of directors is scheduled for December 9, 2025, to review the proposal regarding the cancellation of stock options [2] - A total of 242,250 stock options that were granted but not yet exercisable will be canceled by the company [2] - The cancellation is in accordance with the relevant provisions of the company's 2023 equity incentive plan draft [2]
亚宝药业拟以8719万元将太原制药62%股权出售给同享科技
Zhi Tong Cai Jing· 2025-11-17 14:58
Core Viewpoint - The company plans to sell 62% of its subsidiary, Taiyuan Pharmaceutical Co., Ltd., to Shanxi Tongxiang Times Technology Co., Ltd. for RMB 87.19 million, which will enhance asset operational efficiency and provide funding support for business expansion [1] Group 1: Transaction Details - The transaction price for the 62% stake in Taiyuan Pharmaceutical is RMB 87.19 million [1] - After the transaction, Shanxi Tongxiang will hold 95% of Taiyuan Pharmaceutical, while the company will retain a 5% stake [1] - Taiyuan Pharmaceutical will no longer be included in the company's consolidated financial statements post-transaction [1] Group 2: Strategic Rationale - The transaction is based on comprehensive considerations for the company's future development [1] - It aims to improve asset operational efficiency and reduce management costs [1] - The company anticipates an increase in profit of approximately RMB 59 million for the year 2025 following the completion of the transaction (unaudited) [1]